Evidence map›Paper›PMID 28482051›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2017

Biomarkers of Chronic Acrolein Inhalation Exposure in Mice: Implications for Tobacco Product-Induced Toxicity.

Daniel J Conklin, Marina V Malovichko, Iris Zeller, Trinath P Das, Tatiana V Krivokhizhina, Blake H Lynch, Pawel Lorkiewicz, Abhinav Agarwal, Nalinie Wickramasinghe, Petra Haberzettl and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Five-Day Changes in Biomarkers of Exposure Among Adult Smokers After Completely Switching From Combustible Cigarettes to a Nicotine-Salt Pod System.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  3. Influence of e-cigarettes and their constituents on cardiac rhythm and arrhythmias.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Daniel J ConklinAmerican Heart Association - Tobacco Regulation and Addiction Center.
Marina V MalovichkoAmerican Heart Association - Tobacco Regulation and Addiction Center.
Iris ZellerAmerican Heart Association - Tobacco Regulation and Addiction Center.
Trinath P DasAmerican Heart Association - Tobacco Regulation and Addiction Center.
Tatiana V KrivokhizhinaAmerican Heart Association - Tobacco Regulation and Addiction Center.
Blake H LynchAmerican Heart Association - Tobacco Regulation and Addiction Center.
Pawel LorkiewiczAmerican Heart Association - Tobacco Regulation and Addiction Center.
Abhinav AgarwalAmerican Heart Association - Tobacco Regulation and Addiction Center.
Nalinie WickramasingheAmerican Heart Association - Tobacco Regulation and Addiction Center.
Petra HaberzettlAmerican Heart Association - Tobacco Regulation and Addiction Center.
Srinivas D SithuAmerican Heart Association - Tobacco Regulation and Addiction Center.
Jasmit ShahAmerican Heart Association - Tobacco Regulation and Addiction Center.
Timothy E O'TooleAmerican Heart Association - Tobacco Regulation and Addiction Center.
Shesh N RaiAmerican Heart Association - Tobacco Regulation and Addiction Center.
Aruni BhatnagarAmerican Heart Association - Tobacco Regulation and Addiction Center.
Sanjay SrivastavaAmerican Heart Association - Tobacco Regulation and Addiction Center.
Diabetes Australia · AUAmerican Heart Association · USUniversity of Louisville · US

Funding

Research Training and Education Core (Core D) P50HL120163 · NHLBI · AMERICAN HEART ASSOCIATION · PI BHATNAGAR, ARUNI, ROBERTSON, ROSE MARIE · 2013 to 2017
$20.1M
ConProject-006U54HL120163 · NHLBI · AMERICAN HEART ASSOCIATION · PI BHATNAGAR, ARUNI, ROBERTSON, ROSE MARIE · 2018 to 2022
$18.8M
Project 5 - Metabolomic Analysis of AtherothrombosisP20GM103492 · NIGMS · UNIVERSITY OF LOUISVILLE · PI DEFILIPPIS, ANDREW · 2012 to 2017
$13.8M
Endothelial Progenitor Cells and Particulate Air PollutionR01ES019217 · NIEHS · UNIVERSITY OF LOUISVILLE · PI BHATNAGAR, ARUNI, O'TOOLE, TIMOTHY E · 2011 to 2022
$6.0M
Cardiovascular Toxicity of Tobacco Products and ConstituentsR01HL122676 · NHLBI · UNIVERSITY OF LOUISVILLE · PI CONKLIN, DANIEL JOSEPH · 2015 to 2019
$3.7M
Tobacco Products and Atherosclerotic DiseaseR01HL120746 · NHLBI · UNIVERSITY OF LOUISVILLE · PI SRIVASTAVA, SANJAY · 2013 to 2017
$3.7M
NHLBI NIH HHS P50 HL120163NHLBI NIH HHS R01 HL120746NHLBI NIH HHS R01 HL122676NHLBI NIH HHS U54 HL120163NIEHS NIH HHS R01 ES019217NIGMS NIH HHS P20 GM103492
6 · The paper itself

Abstract

Exposure to tobacco smoke, which contains several harmful and potentially harmful constituents such as acrolein increases cardiovascular disease (CVD) risk. Although high acrolein levels induce pervasive cardiovascular injury, the effects of low-level exposure remain unknown and sensitive biomarkers of acrolein toxicity have not been identified. Identification of such biomarkers is essential to assess the toxicity of acrolein present at low levels in the ambient air or in new tobacco products such as e-cigarettes. Hence, we examined the systemic effects of chronic (12 weeks) acrolein exposure at concentrations similar to those found in tobacco smoke (0.5 or 1 ppm). Acrolein exposure in mice led to a 2- to 3-fold increase in its urinary metabolite 3-hydroxypropyl mercapturic acid (3-HPMA) with an attendant increase in pulmonary levels of the acrolein-metabolizing enzymes, glutathione S-transferase P and aldose reductase, as well as several Nrf2-regulated antioxidant proteins. Markers of pulmonary endoplasmic reticulum stress and inflammation were unchanged. Exposure to acrolein suppressed circulating levels of endothelial progenitor cells (EPCs) and specific leukocyte subsets (eg, GR-1+ cells, CD19+ B-cells, CD4+ T-cells; CD11b+ monocytes) whilst other subsets (eg, CD8+ cells, NK1.1+ cells, Ly6C+ monocytes) were unchanged. Chronic acrolein exposure did not affect systemic glucose tolerance, platelet-leukocyte aggregates or microparticles in blood. These findings suggest that circulating levels of EPCs and specific leukocyte populations are sensitive biomarkers of inhaled acrolein injury and that low-level (<0.5 ppm) acrolein exposure (eg, in secondhand smoke, vehicle exhaust, e-cigarettes) could increase CVD risk by diminishing endothelium repair or by suppressing immune cells or both.

Indexed as

Inhalation ExposureAcroleinAnimalsBiomarkersEndoplasmic Reticulum StressEndothelial CellsInsulin ResistanceLeukocytesMaleMiceMice, Inbred C57BLOxidative StressSmokeTobacco ProductsAcroleinBiomarkersSmokealdehydescardiovascular diseaseendothelial progenitor cellsoxidative stresspulmonary injurytobacco

Identifiers

PMID28482051
PMCPMC5837482
OpenAlexW2612399154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.